Researchers have developed a method that identifies bacteria easily, cheaply and more precisely than before.
Chinese biotech developing semaglutide biosimilar files for Hong Kong IPO
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS